The ability of ImmTACs to detect a low density of pMHCs and to activate immune cells independently of co-receptors and other regulatory cells could circumvent immune tolerance in the tumor microenvironment and overcome inhibitory mechanisms such as MHC down-regulation or the presence of Tregs [8, 9]. The gene discussed is HLA-C; the disease is neoplasm.